These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29611471)

  • 1. Peroxisome Proliferated Activated Receptors (PPARs): Opportunities and Challenges for Ocular Therapy.
    Khatol P; Saraf S; Jain A
    Crit Rev Ther Drug Carrier Syst; 2018; 35(1):65-97. PubMed ID: 29611471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.
    Escandon P; Vasini B; Whelchel AE; Nicholas SE; Matlock HG; Ma JX; Karamichos D
    Exp Eye Res; 2021 Jul; 208():108617. PubMed ID: 34010603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells.
    Usui-Ouchi A; Ouchi Y; Ebihara N
    Int Immunopharmacol; 2017 Nov; 52():70-76. PubMed ID: 28866026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases.
    Zhang S; Gu H; Hu N
    J Ophthalmol; 2015; 2015():275435. PubMed ID: 26146566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
    Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).
    Wu L; Martínez-Castellanos MA; Quiroz-Mercado H; Arevalo JF; Berrocal MH; Farah ME; Maia M; Roca JA; Rodriguez FJ;
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):81-7. PubMed ID: 17674014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
    Emerson MV; Lauer AK
    BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PPAR gamma: a novel pharmacological target against retinal and choroidal neovascularization].
    Bonne C
    J Fr Ophtalmol; 2005 Mar; 28(3):326-30. PubMed ID: 15883500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.
    Zehetner C; Kirchmair R; Huber S; Kralinger MT; Kieselbach GF
    Br J Ophthalmol; 2013 Apr; 97(4):454-9. PubMed ID: 23385630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
    Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG
    Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peroxisome proliferator activated receptor ligands and angiogenesis].
    Sato M
    Nihon Rinsho; 2005 Apr; 63(4):603-8. PubMed ID: 15828227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR-alpha Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration.
    Del V Cano M; Gehlbach PL
    PPAR Res; 2008; 2008():821592. PubMed ID: 18401454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy.
    de Oliveira Dias JR; Rodrigues EB; Maia M; Magalhães O; Penha FM; Farah ME
    Br J Ophthalmol; 2011 Dec; 95(12):1631-7. PubMed ID: 21546514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor and age-related macular degeneration.
    Herzlich AA; Tuo J; Chan CC
    PPAR Res; 2008; 2008():389507. PubMed ID: 18288287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
    Huang TH; Roufogalis BD
    Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.
    Ng EW; Shima DT; Calias P; Cunningham ET; Guyer DR; Adamis AP
    Nat Rev Drug Discov; 2006 Feb; 5(2):123-32. PubMed ID: 16518379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.